Development of a rapid method for the simultaneous separation and determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its N- and O-glucuronides in human urine by liquid chromatography-tandem mass spectrometry

被引:10
|
作者
Yao, Li [1 ]
Zheng, Saijing [2 ]
Guan, Yafeng [1 ,3 ]
Yang, Jun [1 ]
Liu, Baizhan [2 ]
Wang, Weimiao [2 ]
Zhu, Xiaolan [1 ]
机构
[1] Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China
[2] China Natl Tobacco Corp, Key Lab Cigarette Smoke Res, Shanghai 200082, Peoples R China
[3] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Microinstrumentat & Analyt Chem, Dalian 116023, Peoples R China
关键词
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol; Metabolism; Pentafluorophenyl column; Liquid chromatography-tandem mass spectrometry; Solid-phase extraction; Human urine; TOBACCO-SPECIFIC NITROSAMINE; PENTAFLUOROPHENYLPROPYL STATIONARY-PHASE; MOLECULARLY IMPRINTED POLYMER; HUMAN PLASMA; INTERNAL STANDARDS; NATURAL-PRODUCTS; PERFORMANCE; VALIDATION; EXTRACTION; ISOMERS;
D O I
10.1016/j.aca.2013.06.034
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Determination of the tobacco-specific nitrosamine metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol (NNAL) and its N- and O-glucuronides (NNAL-N-Gluc and NNAL-O-Gluc) is important for toxicology analysis of tobacco smoke induced carcinogenicity and the understanding of detoxification mechanisms of the carcinogenic nitrosamine in humans. But previously reported indirect measurement methods involving enzymolysis and base treatment steps were tedious and time-consuming. In this work, a direct measurement method for simultaneous determination of urinary NNAL, NNAL-N-Gluc and NNAL-O-Gluc by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in a single run was developed for the first time without the need to perform enzymatic or base hydrolysis. Urine samples were purified using dichloromethane and further extracted by solid-phase extraction. Then they were analyzed by LC-MS/MS operated in electrospray positive ionization mode. Chromatographic separation was achieved on a Phenomenex Kinetex PFP column within 6 min. The proposed method was validated and the results demonstrated that the method can produce satisfactory recoveries and reproducibility for the analytes. The applicability of this newly developed method was investigated for the simultaneous analysis of the three metabolites in smokers' urine and the obtained results were comparable to those detected using the conventional enzymolysis method. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 67
页数:7
相关论文
共 50 条
  • [41] Development of a Sensitive Method for the Determination of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Human Urine Using Solid-phase Extraction Combined with Ultrasound-assisted Dispersive Liquid-liquid Microextraction and LC-MS/MS Detection
    Liu, Bai-Zhan
    Yao, Li
    Zheng, Sai-Jing
    Wang, Wei-Miao
    Zhu, Xiao-Lan
    Yang, Jun
    JOURNAL OF THE CHINESE CHEMICAL SOCIETY, 2013, 60 (08) : 1055 - 1061
  • [42] Comparison of Creatinine and Specific Gravity for Hydration Corrections on Measurement of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in Urine
    Xia, Yang
    Wong, Lee-Yang
    Bunker, Brandon C.
    Bernert, John T.
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2014, 28 (05) : 353 - 363
  • [43] Characterization of N-glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (nnal) in human liver:: Importance of UDP-glucuronosyltransferase 1A4
    Wiener, D
    Doerge, DR
    Fang, JL
    Upadhyaya, P
    Lazarus, P
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (01) : 72 - 79
  • [44] Combined analysis of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and cotinine in urine by heart cutting two-dimensional LC-MS/MS
    Lin, Huaqing
    Wang, Yangzhong
    Wang, Tiannan
    Wu, Da
    Li, Gang
    Deng, Chunhui
    SEPARATION SCIENCE PLUS, 2018, 1 (12): : 776 - 784
  • [45] Improved method for the measurement of tobacco-specific carcinogen biomarker urinary 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in tobacco users
    Brown, Justin
    Xia, Baoyun
    Lee, John
    Blount, Benjamin
    Wang, Lanqing
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [46] Relationship of human toenail Nicotine, cotinine, and 4-(M ethylnitrosamino)-1-(3-Pyridyl)-1-Butanol to Levels of these Biomarkers in plasma and urine
    Stepanov, Irina
    Hecht, Stephen S.
    Lindgren, Bruce
    Jacob, Peyton
    Wilson, Margaret
    Benowitz, Neal L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (07) : 1382 - 1386
  • [47] Development of liquid chromatography electrospray ionization tandem mass spectrometry methods for analysis of DNA adducts of formaldehyde and their application to rats treated with N-Nitrosodimethylamine or 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
    Wang, Mingyao
    Cheng, Guang
    Villalta, Peter W.
    Hecht, Stephen S.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2007, 20 (08) : 1141 - 1148
  • [48] EFFECT OF MATERNAL TOBACCO SMOKING OR EXPOSURE TO SECOND-HAND SMOKE ON THE LEVELS OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN URINE OF MOTHER AND THE FIRST URINE OF NEWBORN
    Florek, E.
    Piekoszewski, W.
    Basior, A.
    Merritt, A. T.
    Mazela, J.
    Lechowicz, W.
    Kornacka, M. K.
    Kramer, L.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2011, 62 (03): : 377 - 383
  • [49] A STUDY OF TOBACCO CARCINOGENESIS - TUMORIGENIC ACTIVITY OF THE TOBACCO-SPECIFIC NITROSAMINES 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK), 4-(METHYLNITROSAMINO)-4-(3-PYRIDYL)-1-BUTANOL (ISO-NNAL) AND N'-NITROSONORNICOTINE (NNN) ON TOPICAL APPLICATION TO SENCAR MICE
    LAVOIE, EJ
    PROKOPCZYK, G
    RIGOTTY, J
    CZECH, A
    RIVENSON, A
    ADAMS, JD
    CANCER LETTERS, 1987, 37 (03) : 277 - 283
  • [50] Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13
    Jalas, JR
    Ding, XX
    Murphy, SE
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (10) : 1199 - 1202